by pbn | Dec 18, 2024 | Board of Directors
Matthias is a Principal at the BioInnovation Institute in Copenhagen where he anchors several therapeutics and women’s health companies. Prior to joining BII, Matthias worked as an investment analyst at the corporate VC, M Ventures, in Amsterdam, as a pharmacist...
by pbn | May 20, 2024 | Press Releases
2N Pharma CEO, Preben Bruun-Nyzell, and CSO, Dr John Nieland, will participate in the 3rd ALS Drug Development Summit in Boston, 21-23 May 2024. This is a fantastic opportunity to engage with the world’s leading ALS drug development companies.
by pbn | Jan 24, 2023 | Press Releases
Congratulations to Dr Michael Sloth Trabjerg MD, 2N Pharma Co-Founder, CSO and Aalborg University Associate Professor Dr John Dirk Vestergaard Nieland, and collaborators on the publication of their newest article in npj Parkinson’s Disease. The article details their...
by pbn | Dec 1, 2022 | Press Releases
We are so happy that WAPO published an article about the extremely interesting work being carried out by Dr Dina Dechmann, Dr Liliana Dávalos, and 2N Pharma CSO and Aalborg University associate prof. Dr John Dirk Vestergaard Nieland. In the winter, the...
by pbn | Jun 23, 2021 | Press Releases
Aalborg, Denmark, 23 June 2021 – 2N Pharma, a biotech company developing therapeutic drugs to treat neurological disorders, today announced the appointment of Alex Leech as Chair of the Board of Directors and John Kemp as Non-Executive Director. “We are...
Recent Comments